Latest AI and machine learning research in venous thrombosis for healthcare professionals.
BACKGROUND: Direct oral anticoagulants are the first-line drugs for anticoagulation therapy in nonva...
We describe a case of biopsy-proven dabigatran related nephropathy in a patient without underlying I...
Poor electronic medical record (EMR) usability is detrimental to both clinicians and patients. A bet...
Interventional cardiology procedures require full anticoagulation to prevent thrombus formation on c...
Warfarin, for many years, was the only oral anticoagulant availablt on the market for the prevention...
Warfarin dosing remains challenging due to narrow therapeutic index and highly individual variabilit...
Enoxaparin is a low molecular weight heparin commonly used in the treatment of venous thromboembolis...
The impact of direct oral anticoagulants (DOACs) on laboratory assays used for thrombophilia testing...
BACKGROUND: It's difficult but urgent to achieve the individualized rational medication of the warfa...
INTRODUCTION: A prospective study was designed to elucidate incidence and predictors of deep venous ...
OBJECTIVE: Point-of-care (POC) devices allow for prothrombin time/international normalized ratio (PT...
BACKGROUND: It is unclear whether topical (intra-articular) or intravenous TXA reduces blood loss in...
Endosulfan is an organochloride insecticide extensively used in several countries to protect crops f...
There is limited information on compounded apixaban formulations for administration via enteral fee...
OBJECTIVES: This study was designed to assess the physicochemical stability of warfarin sodium liqui...
Anti-protamine (PRT)/heparin antibodies are a newly described class of heparin-dependent antibodies ...
BACKGROUND AND PURPOSE: This study evaluated the use of an artificial intelligence platform on mobil...
BACKGROUND: Trisodium citrate is an interesting alternative to heparin for the prevention of circuit...
BACKGROUND: The APEX trial assessed the safety and efficacy of extended-duration thromboprophylaxis ...
BACKGROUND: Knowledge about drug-drug interactions commonly arises from preclinical trials, from adv...
BACKGROUND: The purpose of this study is to assess incidence and risk factors for severe renal dysfu...